ProCE Banner Activity

Myelofibrosis Therapy in the Second Line and Beyond

Slideset

This downloadable slideset includes expert guidance in selecting optimal treatment for patients with myelofibrosis following JAK inhibitor failure.

Released: May 30, 2024

Expiration: May 29, 2025

Share

Faculty

Lucia Masarova

Lucia Masarova, MD

Assistant Professor
Leukemia Department
Division of Cancer Medicine
MD Anderson Cancer Center
Houston, Texas

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by an educational grant from GlaxoSmithKline.

GlaxoSmithKline